Chiba University
↗Chiba, Japan
Chiba University is a leading Japanese national research university with a distinguished history in medical and pharmaceutical sciences dating back to 1874. It is recognized as one of Japan's premier institutions for clinical research, operating the Chiba University Hospital and the Chiba University Clinical Research Center (CCRC), the largest Academic Research Organization (ARO) in Japan. The university is a core hub for translational research, specializing in the development of innovative therapeutics, including gene therapies, regenerative medicine, and oncology treatments.
The university's 'Inohana Campus' serves as a strategic medical research cluster, integrating the Schools of Medicine, Pharmaceutical Sciences, and Nursing with the university hospital. Chiba University is a designated 'Core Clinical Research Center' by the Japanese Ministry of Health, Labour and Welfare (MHLW), playing a critical role in national drug development strategies, regulatory science education, and the clinical trial ecosystem in the Greater Tokyo Biocommunity.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:1949
Ownership:government
Status:operating
FUNDING
Investors:Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Agency for Medical Research and Development (AMED), Japan Science and Technology Agency (JST)
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2
Modalities:Cell therapy, Gene therapy, Small molecule, mAb, Digital Health (CBT), Lipid Nanoparticles, Vaccines
Active Trials:187
Trial Phases:Phase 1: 45 | Phase 2: 30 | Phase 3: 10 | Phase 4: 100
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Chiba University Hospital, Clinical Research Center (CCRC), Medical Mycology Research Center
Key Partnerships:Takeda Pharmaceutical (Sponsored Laboratory of Physicochemistry and Preformulation Research), Duke Clinical Research Institute (Global ARO collaboration), MatsukiyoCocokara & Co (Drug Informatics sponsorship), University of California San Diego (iMeC-WISE joint doctoral program), PMDA (Personnel exchange and regulatory science collaboration)
COMPETITION
Position:Leader
Competitors:University of Tokyo, Kyoto University, Osaka University, Keio University
LEADERSHIP
Key Executives:
Kotaro Yokote - President
Takashi Miki - Dean, Graduate School of Medicine
Yasumitsu Ogra - Dean, Graduate School of Pharmaceutical Sciences
Itsuko Ishii - Director of Pharmacy / Professor
LINKS
Website:chiba-u.jp
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Chiba University. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.